Indian Journal of Dental ResearchIndian Journal of Dental ResearchIndian Journal of Dental Research
HOME | ABOUT US | EDITORIAL BOARD | AHEAD OF PRINT | CURRENT ISSUE | ARCHIVES | INSTRUCTIONS | SUBSCRIBE | ADVERTISE | CONTACT
Indian Journal of Dental Research   Login   |  Users online:

Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size         

    Article Cited by others

SYSTEMATIC REVIEW

Epidermal growth factor receptor: Role in human cancer

Rajaram Prashanth, Chandra Poornima, Ticku Smriti, Pallavi B K, Rudresh K B, Mansabdar Poorva

Year : 2017| Volume: 28| Issue : 6 | Page no: 687-694

   This article has been cited by
 
1 Aspects of Phage-Based Vaccines for Protein and Epitope Immunization
Marco Palma
Vaccines. 2023; 11(2): 436
[Pubmed]  [Google Scholar] [DOI]
2 EGFR-Targeted Cellular Delivery of Therapeutic Nucleic Acids Mediated by Boron Clusters
Damian Kaniowski, Justyna Suwara, Katarzyna Ebenryter-Olbinska, Agata Jakóbik-Kolon, Barbara Nawrot
International Journal of Molecular Sciences. 2022; 23(23): 14793
[Pubmed]  [Google Scholar] [DOI]
3 The anticancer effect of EGFR -targeting artificial microRNA controlled by SLPI promoter in nasopharyngeal carcinoma
Feilin Dong, Lizhong Su, Jun Tan, Hui Luo
Journal of Clinical Laboratory Analysis. 2022;
[Pubmed]  [Google Scholar] [DOI]
4 Predicting Novel Drug Candidates for Pancreatic Neuroendocrine Tumors via Gene Signature Comparison and Connectivity Mapping
Yao Xiao, Gang Xu, Jordan M. Cloyd, Shunda Du, Yilei Mao, Timothy M. Pawlik
Journal of Gastrointestinal Surgery. 2022;
[Pubmed]  [Google Scholar] [DOI]
5 Systems Biology Approach to Investigate Biomarkers, Boron-10 Carriers, and Mechanisms Useful for Improving Boron Neutron Capture Therapy
Davide Perico, Dario Di Silvestre, Shoji Imamichi, Yu Sanada, Mitsuko Masutani, Pier Luigi Mauri
Cancer Biotherapy and Radiopharmaceuticals. 2022;
[Pubmed]  [Google Scholar] [DOI]
6 Noninvasive Evaluation of EGFR Expression of Digestive Tumors Using 99mTc-MAG3-Cet-F(ab ' )
Dai Shi, Yiqiu Zhang, Zhan Xu, Zhan Si, Yuan Cheng, Dengfeng Cheng, Guobing Liu, Walter Akers
Molecular Imaging. 2022; 2022: 1
[Pubmed]  [Google Scholar] [DOI]
7 Triptonide Inhibits the Cervical Cancer Cell Growth via Downregulating the RTKs and Inactivating the Akt-mTOR Pathway
Li-na Zhou, Shi-qing Peng, Xue-Lian Chen, Xiao-ren Zhu, An-qi Jin, Yuan-yuan Liu, Li-xia Zhu, Ya-qun Zhu, Maria Isaguliants
Oxidative Medicine and Cellular Longevity. 2022; 2022: 1
[Pubmed]  [Google Scholar] [DOI]
8 Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target
Sven Jonckheere, Jamie Adams, Dominic De Groote, Kyra Campbell, Geert Berx, Steven Goossens
Cells Tissues Organs. 2022; 211(2): 157
[Pubmed]  [Google Scholar] [DOI]
9 Reciprocal EGFR signaling in the anchor cell ensures precise inter-organ connection during Caenorhabditis elegans vulval morphogenesis
Silvan Spiri, Simon Berger, Louisa Mereu, Andrew DeMello, Alex Hajnal
Development. 2022; 149(1)
[Pubmed]  [Google Scholar] [DOI]
10 Low expression of miR-27b in serum exosomes of non-small cell lung cancer facilitates its progression by affecting EGFR
Xiying Cao, Weixiang Zhong, Shaoming Guo, Zuxiong Zhang, Chunfa Xie
Open Medicine. 2022; 17(1): 816
[Pubmed]  [Google Scholar] [DOI]
11 Personalized Targeted Therapeutic Strategies against Oral Squamous Cell Carcinoma. An Evidence-Based Review of Literature
Mingxin Cao, Enyu Shi, Hanping Wang, Lujia Mao, Qiqi Wu, Xinming Li, Yanjie Liang, Xiaoying Yang, Yinsong Wang, Changyi Li
International Journal of Nanomedicine. 2022; Volume 17: 4293
[Pubmed]  [Google Scholar] [DOI]
12 Nimotuzumab Combined with Neoadjuvant or Induction Chemotherapy for Head and Neck Squamous Cell Carcinoma: A Retrospective Study
Huihui Zhang, Jing Yan, Xiaoyong Ren, Ying Sheng, Zhenghui Wang, Jianmin Liang, Yan Yan, Yangyang Jia, Zhihui Li, Jin Hou
Oncologie. 2022; 24(4): 707
[Pubmed]  [Google Scholar] [DOI]
13 Cooperation between Angiogenesis, Vasculogenesis, Chemotaxis, and Coagulation in Breast Cancer Metastases Development: Pathophysiological Point of View
Elzbieta Zarychta, Barbara Ruszkowska-Ciastek
Biomedicines. 2022; 10(2): 300
[Pubmed]  [Google Scholar] [DOI]
14 Discovering Common miRNA Signatures Underlying Female-Specific Cancers via a Machine Learning Approach Driven by the Cancer Hallmark ERBB
Katia Pane, Mario Zanfardino, Anna Maria Grimaldi, Gustavo Baldassarre, Marco Salvatore, Mariarosaria Incoronato, Monica Franzese
Biomedicines. 2022; 10(6): 1306
[Pubmed]  [Google Scholar] [DOI]
15 Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions
Niklas Sturm, Jasmin Selina Schuhbaur, Felix Hüttner, Lukas Perkhofer, Thomas Jens Ettrich
Cancers. 2022; 14(22): 5580
[Pubmed]  [Google Scholar] [DOI]
16 Cisplatin Plus Cetuximab Inhibits Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Migration and Proliferation but Does Not Enhance Apoptosis
Hyeong Sim Choi, Young-Kyun Kim, Pil-Young Yun
International Journal of Molecular Sciences. 2021; 22(15): 8167
[Pubmed]  [Google Scholar] [DOI]
17 Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes
Wei Qi, Qian Yan, Ming Lv, Delei Song, Xianbin Wang, Kangsong Tian
Pathology and Oncology Research. 2021; 27
[Pubmed]  [Google Scholar] [DOI]
18 Evaluation of TGF-ß1 and EGFR in Cleft Affected Lip Mucosa
Olga Rimdenoka, Mara Pilmane
Acta medica Lituanica. 2021; 28(1): 86
[Pubmed]  [Google Scholar] [DOI]
19 Diffusion Reflection Method for Early Detection of Oral Squamous Cell Carcinoma Specifically Targeted by Circulating Gold-Nanorods Bio-Conjugated to Anti-Epidermal Growth Factor Receptor
Shiran Sudri, Hamootal Duadi, Florin Altman, Irit Allon, Ariel Ashkenazy, Ruchira Chakraborty, Ilya Novikov, Dror Fixler, Abraham Hirshberg
International Journal of Nanomedicine. 2021; Volume 16: 2237
[Pubmed]  [Google Scholar] [DOI]
20 Exposure to chewing tobacco promotes primary oral squamous cell carcinoma and regional lymph node metastasis by alterations of SDF1a/CXCR4 axis
Sudipta Ray, Depanwita Saha, Neyaz Alam, Saunak Mitra Mustafi, Shyamsundar Mandal, Aniruddha Sarkar, Biswanath Majumder, Nabendu Murmu
International Journal of Experimental Pathology. 2021; 102(2): 80
[Pubmed]  [Google Scholar] [DOI]
21 Enhanced cancer therapeutic efficiency of NO combined with siRNA by caspase-3 responsive polymers
Yi Yan, Cheng-Han Wang, Shi-He Cui, Lin Zhai, Jing Sun, Xiao-Yu Liu, Xin Chen, Yi Sun, Hong-Gang Qian, Xiang Gao, Yi-Da Tang, Yuan-Jun Zhu, Yu-Jie Shi, Qiang Zhang, Jian-Cheng Wang
Journal of Controlled Release. 2021; 339: 506
[Pubmed]  [Google Scholar] [DOI]
22 Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects
X. Zhao, A. Chen, Z. Wang, Xiao-Han Xu, Y. Tao
Clinical and Translational Oncology. 2021;
[Pubmed]  [Google Scholar] [DOI]
23 Role of epidermal growth factor receptor signaling in a Pt(II)-resistant human breast cancer cell line
A. Muscella, E. Stefŕno, N. Calabriso, SA. De Pascali, FP. Fanizzi, S. Marsigliante
Biochemical Pharmacology. 2021; 192: 114702
[Pubmed]  [Google Scholar] [DOI]
24 Discovery of CAPE derivatives as dual EGFR and CSK inhibitors with anticancer activity in a murine model of hepatocellular carcinoma
Xiaoyu Liu, Qianqian Du, Caiping Tian, Mei Tang, Yingjun Jiang, Yong Wang, Yang Cao, Zhe Wang, Zhenwei Wang, Jing Yang, Yan Li, Xiaozhen Jiao, Ping Xie
Bioorganic Chemistry. 2021; 107: 104536
[Pubmed]  [Google Scholar] [DOI]
25 Engineered nanomedicines for tumor vasculature blockade therapy
Duoyi Zhao, Xu Huang, Zhiyu Zhang, Jianxun Ding, Yan Cui, Xuesi Chen
WIREs Nanomedicine and Nanobiotechnology. 2021; 13(3)
[Pubmed]  [Google Scholar] [DOI]
26 Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy
Sarbjit Singh, Divya Utreja, Vimal Kumar
Medicinal Chemistry Research. 2021;
[Pubmed]  [Google Scholar] [DOI]
27 CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR -665-dependent regulation of EGFR
Mingqiang Dong, Peng Li, Yuquan Xie, Zhihua Wang, Rui Wang
Drug Development Research. 2021;
[Pubmed]  [Google Scholar] [DOI]
28 MERTK Inhibition: Potential as a Treatment Strategy in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer
Chao-Ju Chen, Yu-Peng Liu
Pharmaceuticals. 2021; 14(2): 130
[Pubmed]  [Google Scholar] [DOI]
29 Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy
Annamaria Aloisio, Nancy Nisticň, Selena Mimmi, Domenico Maisano, Eleonora Vecchio, Giuseppe Fiume, Enrico Iaccino, Ileana Quinto
Viruses. 2021; 13(4): 649
[Pubmed]  [Google Scholar] [DOI]
30 Biological activities of siRNA-loaded lanthanum phosphate nanoparticles on colorectal cancer
Piao-Piao Li, Yi Yan, Hai-Tao Zhang, Shi-he Cui, Cheng-Han Wang, Wei Wei, Hong-Gang Qian, Jian-Cheng Wang, Qiang Zhang
Journal of Controlled Release. 2020; 328: 45
[Pubmed]  [Google Scholar] [DOI]
31 Prediction of Human Pharmacokinetics and Clinical Effective Dose of SI–B001, an EGFR/HER3 Bi-specific Monoclonal Antibody
Junsheng Xue, Daming Kong, Ye Yao, Liang Yang, Qingyu Yao, Yi Zhu, Yang Ding, Fen Yang, Jifang Gong, Lin Shen, Tianyan Zhou
Journal of Pharmaceutical Sciences. 2020; 109(10): 3172
[Pubmed]  [Google Scholar] [DOI]
32 Overview of current targeted therapy in gallbladder cancer
Xiaoling Song, Yunping Hu, Yongsheng Li, Rong Shao, Fatao Liu, Yingbin Liu
Signal Transduction and Targeted Therapy. 2020; 5(1)
[Pubmed]  [Google Scholar] [DOI]
33 Identification and Verification of Core Genes in Colorectal Cancer
Houxi Xu, Yuzhu Ma, Jinzhi Zhang, Jialin Gu, Xinyue Jing, Shengfeng Lu, Shuping Fu, Jiege Huo
BioMed Research International. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
34 Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer
Xiao-Lin Su, Jiang-Wei Wang, Hui Che, Chang-Fu Wang, Hai Jiang, Xia Lei, Wan Zhao, Hai-Xue Kuang, Qiu-Hong Wang
Chinese Medical Journal. 2020; 133(24): 2987
[Pubmed]  [Google Scholar] [DOI]
35 Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) know
Simone Camelliti, Valentino Le Noci, Francesca Bianchi, Claudia Moscheni, Francesca Arnaboldi, Nicoletta Gagliano, Andrea Balsari, Marina Chiara Garassino, Elda Tagliabue, Lucia Sfondrini, Michele Sommariva
Journal of Experimental & Clinical Cancer Research. 2020; 39(1)
[Pubmed]  [Google Scholar] [DOI]
36 Metabolism and Distribution of Novel Tumor Targeting Drugs In Vivo
Mengli Wang, Qiuzheng Du, Lihua Zuo, Peng Xue, Chao Lan, Zhi Sun
Current Drug Metabolism. 2020; 21(13): 996
[Pubmed]  [Google Scholar] [DOI]
37 Actively targeted nanocarriers for drug delivery to cancer cells
Stefania Biffi,Rebecca Voltan,Barbara Bortot,Giorgio Zauli,Paola Secchiero
Expert Opinion on Drug Delivery. 2019; 16(5): 481
[Pubmed]  [Google Scholar] [DOI]
38 Actively targeted nanocarriers for drug delivery to cancer cells
Stefania Biffi,Rebecca Voltan,Barbara Bortot,Giorgio Zauli,Paola Secchiero
Expert Opinion on Drug Delivery. 2019; 16(5): 481
[Pubmed]  [Google Scholar] [DOI]
39 Prognostic markers in salivary gland cancer and their impact on survival
Mateusz Szewczyk,Andrzej Marszalek,Jacek Sygut,Pawel Golusinski,Wojciech Golusinski
Head & Neck. 2019; 41(9): 3338
[Pubmed]  [Google Scholar] [DOI]
40 Prognostic markers in salivary gland cancer and their impact on survival
Mateusz Szewczyk,Andrzej Marszalek,Jacek Sygut,Pawel Golusinski,Wojciech Golusinski
Head & Neck. 2019; 41(9): 3338
[Pubmed]  [Google Scholar] [DOI]
41 USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway
Yawen Tan, Guanglin Zhou, Xianming Wang, Weicai Chen, Haidong Gao
International Journal of Oncology. 2018;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article